SCHEMBL20569401

SCHEMBL20569401

CC(C)(C)OC(=O)C(CN)OCCO

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.32
NOS1 P29475 2/20 0.31
NOS3 P29474 1/20 0.31
NOS2 P35228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12527313 0.84 TDP1 (0.33) TDP1
SCHEMBL1937378 0.81 APLNR (0.30)
SCHEMBL674128 0.79 CPB1 (0.34) NOS1NOS3NOS2
SCHEMBL6804922 0.77 NOS1 (0.33) NOS1NOS3NOS2
SCHEMBL29086267 0.75 CPB1 (0.32) NOS1NOS3NOS2
SCHEMBL12171728 0.75 MEN1 (0.35)
SCHEMBL5968150 0.71 CYP4F2 (0.32) TDP1
SCHEMBL5828857 0.71 TDP1 (0.32) TDP1
SCHEMBL3205535 0.71 NOS1 (0.34) NOS1NOS3NOS2
SCHEMBL30874619 0.70 NOS1 (0.35) NOS1NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630759-A1 ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT Centre National De La Recherche Scientifique (FR) 2020-04-08 EP disclosed
WO-2018215557-A1 ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-11-29 WO disclosed